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sants, while nonsteroidal anti-inflammatory 
drugs (NSAIDs), other pain relievers and 
headache-specific triptans are used, among 
 IntroduCtIon
Chronic Daily Headache (CDH) is 
among the most frequent and disabling neu-
rological conditions, affecting 4% to 5% of 
the general population [1] and being one of 
the main causes of disability for the adults 
[2]. CDH is a category comprising differ-
ent disorders, all of them presenting with 
headache attacks occurring at least 15 days 
a month [1]. A large burden comes from 
Chronic Migraine (CM), which affects ap-
proximatively 2% of the general population 
[3] and consists of migraine attacks occur-
ring at least 15 days per month [4].
Treatment of CDH usually involves pre-
ventative therapy to be taken daily in order 
to prevent attacks, and attack therapy to be 
taken every time a headache attack starts [5]. 
Common preventative headache drugs are, 
for instance, anticonvulsants and antidepres-
Why do we describe this case
We describe this case to underline that 
chronic headache can be successfully 
addressed using a biopsychosocial fra-
mework. Tailored psychological inter-
ventions in conjunction with medical 
therapy might be able to enhance cli-
nical and psychosocial outcomes. Many 
headache triggering or interfering with 
headache and its management factors 
are grounded on a behavioral level, then 
psychological interventions might help 
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Case report
Abstract
According to the biopsychosocial model, biological, psychological, and social factors entwine 
and influence each other bi-directionally concerning health conditions. Therefore, especially in 
disorders such as chronic headache, where behavioral and environmental factors are prominent 
risk factors and triggers, psychosocial interventions might contribute to reduce the burden of the 
health condition and related affective disorders and disability.
We present the case of a Medication Overuse Headache patient self-reporting psychosocial and 
cognitive issues, that prompted further clinical-psychological and neuro-cognitive assessment 
and eventually psychological interventions targeted at headache management in conjunction 
with medical treatment. Psychological interventions were tailored to the patient’s features and 
presentation and were successful in reducing headache attacks in terms of intensity, frequency, 
and debilitation, thereby resulting also in a better perceived general health.
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others, as attack treatments [5]. Another 
preventative pharmacological option for 
CM consists of periodical botulinum toxin 
injections [6].
Medication Overuse Headache (MOH) 
is a CDH caused by the patient’s excessive 
use of pain medications [4]. It is a disabling 
condition rooted in a compulsive behavior 
and it might need a complex setting of care 
in order to be effectively treated: lack of con-
trol in regards to medication usage and other 
co-existing behavioral problems need to be 
addressed [7]. There is a high prevalence of 
mental health problems among CDH suf-
ferers, that can constitute an obstacle to an 
effective management of the condition [8]. 
Chronic headache disorders might then 
need a comprehensive approach with treat-
ments aimed not only at reducing frequency 
and severity of the headache episodes, but 
also at decreasing the effects of headache on 
psychosocial functioning [9]. Clinicians may 
want to consider all factors co-determining 
disorder onset, progression, severity, and dis-
ability in order to provide effective care [9].
In later decades, a theoretical model un-
derlining the interaction of physiological, 
psychological (cognitive, behavioral, and 
affective) and social (environmental, work, 
and family) factors has emerged as a com-
prehensive model of understanding and 
treating chronic headache, the biopsycho-
social model [10]. According to this model, 
biological, psychological, and social factors 
entwine and bi-directionally influence each 
other [10]. Therefore, including psychoso-
cial principles and interventions in a setting 
of care might contribute to reduce health 
condition burden and related psychosocial 
problems [9]. The most common reason for 
referring a headache patient to a clinical 
psychologist, a counseling psychologist, or 
a psychotherapist is the presence of major 
mental health and behavioral disorders like 
mood disorders, anxiety disorders, sleep dis-
order, eating disorders, and addictions [9]. 
Other reasons for a psychological referral are 
cognitive and behavioral elements related to 
ineffective management of the health con-
dition such as poor trigger management, 
poor stress management, and excessive use 
of medications [9].
Various methods of psychological inter-
vention are available in headache and pain 
management [11] and we present a case of 
a chronic headache with excessive use of 
medications treated, according to the bio-
psychosocial model, with medical therapy 
and supportive psychological interventions 
tailored to the patient’s features and pre-
sentation.
CAse desCrIptIon
The patient is a female 52-year-old home-
maker, married and living with her husband 
and mother, who was referred by her gen-
eral practitioner and came to the Centre for 
Headache in the fall of 2014 (T1). She had a 
15-year clinical history of chronic migraine 
(CM) and no other significant medical con-
dition. She also reported high level of stress, 
feeling the burden of her homemaker and 
caregiver duties and reported anxious symp-
toms. During the previous 15 years, she had 
a semi-continuous use of different NSAIDs, 
mostly as self-medication, such as ibuprofen, 
ketoprofen, and recently diclofenac 50 mg 
(she would occasionally take up to 150 mg 
in a day). She reported having used under 
prescription 100 mg of topiramate per day 
as a preventative therapy years ago without 
satisfactory results. She referred pulsating 
and stabbing headache attacks located in 
left and right (not simultaneously) tempo-
ral and orbital head areas. She reported 30 
Headache Days Per Month (HDPM). She 
would rate 9 out of 10 her usual headaches 
on the pain Numerical Rating Scale (NRS). 
The attacks would last from 4 to 12 hours. 
She had often nausea, photophobia, and 
phonofobia during attacks. The neurological 
examination had otherwise normal findings.
Brain magnetic resonance imaging (MRI) 
showed an occipital arachnoid cyst that 
was considered being likely asymptomatic. 
Venous magnetic resonance angiography 
(vMRA) was negative. At the psychological 
evaluation, the patient reported significant 
levels of anxiety and cognitive issues, es-
pecially regarding memory, attention, and 
focusing. The patient completed question-
naires regarding anxiety (Zung Self-Rating 
Anxiety Scale = 45; normal values: 20-40), 
depression (Zung Self-Rating Depression 
Scale = 38; n.v. = 20-43), cognitive function-
ing (Cognitive Failure Questionnaire = 36; 
n.v. = 0-42) and disability (Migraine Dis-
ability Assessment – MIDAS = 56; n.v. < 21).
The patient was diagnosed probable Med-
ication Overuse Headache (pMOH) and 
was prescribed levetiracetam (250 mg to 500 
mg per day) as a preventative therapy and 
almotriptan (12.5 mg) as an attack therapy. 
In addition, the patient was advised to avoid 
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taking NSAIDs for the headache and to 
compile a headache diary.
After three months (T2), headache fre-
quency, intensity, and disability were slight-
ly reduced (25 HDPM; NRS = 8; MIDAS 
= 48). Examining the headache diary, it 
emerged that adherence to therapy was 
partial and NSAIDs were still used albeit 
in a reduced scale. The MOH diagnosis was 
confirmed. The patient kept reporting her 
psychosocial issues. Even though no major 
emotional or cognitive impairment was 
evident at the interview, a more compre-
hensive neuro-cognitive and clinical-psy-
chological assessment was performed. 
General cognitive efficiency, memory, con-
structional praxis, and executive functions 
were assessed. Personality was assessed us-
ing Minnesota Multiphasic Personality 
Inventory (MMPI-2), that showed no 
psychopathological scores, and Barratt Im-
pulsiveness Scale (BIS-11), that showed 
mild personal impulsivity. The neuropsy-
chological profile was borderline regarding 
general cognitive efficiency, abstract logical 
reasoning, prose memory, semantic fluency, 
spatial planning, and attention. Perfor-
mance deficits were detected in visual 
short-term memory, verbal long-term 
memory, visual long-term memory, phone-
mic fluency. These findings were not suf-
ficient for a neuro-cognitive or psycho-
pathological diagnosis, but they had none-
theless psychometric value in terms of 
patient’s understanding. It was hypothe-
sized that a probable executive impairment 
could relate with behavioral aspects rele-
vant to MOH and chronic headache, such 
as non-adherence and compulsive medica-
tion use [12].
Considering that the patient could benefit 
from psychological and educational inter-
ventions in conjunction to the medical ther-
apy, she was proposed to attend a number 
of 6 psychological sessions during the fol-
lowing 2 months. The patient was advised to 
continue medical therapy as prescribed be-
fore. During the psychological sessions some 
cognitive, behavioral, affective, and personal-
ity elements relevant to headache manage-
ment were addressed. Initially, using diaries, 
headache triggers were identified and their 
relationship with affective states of anxiety, 
anger, frustration, and depletion of mood 
was explored. Health behaviors and adher-
ence to medication usage were emphasized 
with a focus on personal ability to actively 
pursue headache management with effective 
Figure 1. Headache 
frequency reduction
T1 = first visit; 
T2 = first follow-up visit 
(after three months); 
T3 = second follow-up 
visit (after six months)





T2 = first follow-up visit 
(after three months); 
T3 = second follow-up 
visit (after six months)
behavioral strategies. The importance of ad-
hering to the prescribed medical therapy and 
communicating with the health care team 
was stressed. The patient was taught self-
pacing and relaxation techniques aimed at 
helping her in reducing perceived stress and 
health-related and psychosocial anxiety. The 
importance of a healthy lifestyle in terms of 
eating, sleeping, and physical activity was 
pointed out.
Three months after her last neurological 
visit, at a follow-up (T3), diaries revealed a 
better adherence and the patient communi-
cated reduction of headache attacks in terms 
of intensity, frequency, and debilitation (11 
HDPM; NRS = 7; MIDAS = 20), while re-
ferring an increased confidence in managing 
her headaches and a better perceived general 
health (Figures 1 and 2).
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for migraine prevention, topiramate (level 
I recommendation) [6], then she was pre-
scribed to switch to another medication, 
levetiracetam (off-label) [6,14]. In order 
to obtain better results, the patient had to 
stop overusing NSAIDs and was prescribed 
almotriptan (level I recommendation) [6] 
when needed. As she showed only partial 
improvement and was apparently still over-
using NSAIDs, then it was proposed a be-
havioral approach in addition to the medical 
therapy and avoiding NSAIDs, in order to 
try and remove some obstacles to personal 
headache management.
This practice is compliant to literature and 
recommendations when some behavioral 
factors are relevant in a chronic headache 
patient [6,9,13]. In this case, excessive us-
age of medications, poor adherence, anxiety 
and some problems with coping headache 
and stress management were criteria that 
prompted the psychological referral.
Main strength of this report is that it pres-
ents a case treated using a model of care con-
sistent with the biopsychosocial model and 
the most updated guidelines: interventions 
were tailored to the patient’s features, con-
sistently with literature about psychological 
headache management. Headache chronic 
patients that overuse medications present a 
obsessive-compulsive personality disorder: 
psychological management improves the 
patients’ compliance to migraine prevention 
therapy and takes care of the psychological 
disorder aspect.
Main weakness is that, being this a single-
case study, it is not possible to demonstrate 
or quantify the contribution provided by 
psychological management.
ConClusIon
All factors that determine headache onset, 
progression, and remission must be consid-
ered: when personal, behavioral, and envi-
ronmental appear relevant, it is important 
to carefully assess these aspects and evalu-
ate the opportunity of support the medical 
approach with psycho-social interventions, 
consistently with the biopsychosocial ap-
proach. This might help removing some 
obstacles in headache management and 
improving outcomes.
Key points
 y Medication Overuse Headache (MOH) is a Chronic Daily Headache caused by excessive 
use of pain medications
 y The biopsychosocial model is a recent theoretical model underlining the interaction of 
physiological, psychological, and social factors that can help in understanding and trea-
ting chronic headache
 y Among the reasons for referring a headache patient to psychological support, there are not 
only the presence of major mental health and behavioral disorders (e.g. mood disorders, 
anxiety disorders, sleep disorder, eating disorders, and addictions), but also poor trigger 
management, poor stress management, and excessive use of medications
 y According to the biopsychosocial model, a tailored psychological support, together with the 
most suitable medical therapy, may result in reduction of headache attacks in terms of in-
tensity, frequency, debilitation and in a better perceived general health
dIsCussIon
Different guidelines about headache have 
included several psychological and behav-
ioral therapies, mostly as an auxiliary treat-
ment, with various levels of recommendation 
[5,6,13]. Recommended psychological and 
behavioral interventions are, among others:
 y Trigger management [13] (level III evi-
dence, class B recommendation);
 y Stress management [5,13];
 y Cognitive-behavioral therapy [6,13] 
(level II evidence, class B recommenda-
tion [13]);
 y Relaxation techniques [6,13] (level II 
evidence, class B recommendation); and
 y Patient education (level III evidence, class 
B recommendation) [13].
Psychological interventions for headache 
patients are advisable when at least one of 
the following criteria is met [9]:
 y Personal factors that negatively influence 
headache management (e.g. beliefs about 
headache controllability and patient’s own 
ability; personality traits);
 y Poor adherence;
 y Poor trigger management;
 y Poor coping with headache;
 y Medications overuse;
 y Poor stress management; and
 y Psychiatric comorbidity or other behav-
ioral disorders.
It has to be underlined that psychological 
interventions in pain management are not 
substitutes of medical therapy, but they are 
intended to be used in conjunction with it. 
The considered case had a history of chronic 
headache and unsatisfactory past therapeu-
tic results, characterized by a huge misuse 
of pain medications. Since the patient had 
previously and unsuccessfully taken therapy 
Main questions a doctor should ask him/herself in this situation
 y Does imaging show any previously undetected finding?
 y Does the patient overuse NSAIDs? 
 y Have I assessed anxiety, depression, cognitive functioning, and 
disability?
 y Does the patient need a more in-depth psychological analysis? Does 
he/she need to attend psychological sessions?
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